COVID-19-induced granulomatosis with polyangiitis
Vijairam Selvaraj, Abdelmoniem Moustafa, Kwame Dapaah-Afriyie, Mark Birkenbach
Abstract
COVID-19 and granulomatosis with polyangiitis share many clinical and radiological features, making it challenging for clinicians to distinguish between the two. In this case report, we describe a patient who was diagnosed with COVID-19 in October 2020. One month later, she presented with persistent fatigue, shortness of breath and anaemia with worsening renal functions, found to have elevated antineutrophil cytoplasmic antibodies and antiproteinase 3 antibodies, and diagnosed with granulomatosis with polyangiitis.
Topics & Concepts
Granulomatosis with polyangiitisMedicineCoronavirus disease 2019 (COVID-19)Anti-neutrophil cytoplasmic antibodyMicroscopic polyangiitis2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VasculitisRadiological weaponDermatologyInternal medicinePathologyRadiologyDiseaseInfectious disease (medical specialty)OutbreakVasculitis and related conditionsCOVID-19 Clinical Research StudiesInflammasome and immune disorders